SCHEDULE 13G/A: Janus Henderson Group Discloses Minimal Stake in Perspective Therapeutics
Beneficial Ownership Report (Schedule 13G Amendment)
Janus Henderson Group plc has filed an amended Schedule 13G, reporting a beneficial ownership of 0.0% in Perspective Therapeutics Inc. as of December 31, 2024.
Summary
- Janus Henderson Group plc, a Jersey-based parent holding company and investment adviser, filed an Amendment No. 1 to Schedule 13G.
- The filing reports beneficial ownership in Perspective Therapeutics Inc.'s Common Stock.
- As of December 31, 2024, Janus Henderson Group plc beneficially owned 17,839 shares of Perspective Therapeutics Inc.
- This ownership represents 0.0% of the class of securities.
- Janus Henderson Group plc holds shared voting and shared dispositive power over all 17,839 shares.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing (Schedule 13G) reporting beneficial ownership, which is inherently neutral in sentiment. It does not contain positive or negative operational or financial news about the issuer.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the issuer's operations or financial performance.
Industry Context
This filing is a routine disclosure by an institutional investor, Janus Henderson Group plc, regarding its passive ownership stake in Perspective Therapeutics Inc. It reflects standard portfolio management activities rather than a strategic industry move or significant investment thesis.
Stakeholder Impact
- Shareholders: Provides transparency regarding a minor institutional ownership stake, confirming no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of Power of Attorney execution by Janus Henderson Group plc. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-02-14 | Date the Schedule 13G/A was signed by Janus Henderson Group plc. |
Keywords
Janus Henderson Group, Perspective Therapeutics, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Parent Holding Company, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.